S&P 500   4,576.01 (+0.03%)
DOW   35,659.22 (-0.27%)
QQQ   382.12 (+0.79%)
AAPL   149.33 (+0.01%)
MSFT   323.76 (+4.40%)
FB   315.44 (-0.12%)
GOOGL   2,956.75 (+6.12%)
TSLA   1,051.03 (+3.20%)
AMZN   3,399.17 (+0.68%)
NVDA   248.76 (+0.64%)
BABA   168.97 (-0.60%)
NIO   39.81 (-1.63%)
CGC   13.02 (-1.14%)
GE   104.15 (-3.06%)
AMD   124.40 (+1.20%)
MU   68.33 (-0.88%)
T   25.19 (-0.71%)
F   15.73 (-1.32%)
ACB   6.96 (-1.00%)
DIS   169.69 (-1.37%)
PFE   42.85 (-1.63%)
BA   207.30 (-1.20%)
AMC   35.35 (-1.94%)
S&P 500   4,576.01 (+0.03%)
DOW   35,659.22 (-0.27%)
QQQ   382.12 (+0.79%)
AAPL   149.33 (+0.01%)
MSFT   323.76 (+4.40%)
FB   315.44 (-0.12%)
GOOGL   2,956.75 (+6.12%)
TSLA   1,051.03 (+3.20%)
AMZN   3,399.17 (+0.68%)
NVDA   248.76 (+0.64%)
BABA   168.97 (-0.60%)
NIO   39.81 (-1.63%)
CGC   13.02 (-1.14%)
GE   104.15 (-3.06%)
AMD   124.40 (+1.20%)
MU   68.33 (-0.88%)
T   25.19 (-0.71%)
F   15.73 (-1.32%)
ACB   6.96 (-1.00%)
DIS   169.69 (-1.37%)
PFE   42.85 (-1.63%)
BA   207.30 (-1.20%)
AMC   35.35 (-1.94%)
S&P 500   4,576.01 (+0.03%)
DOW   35,659.22 (-0.27%)
QQQ   382.12 (+0.79%)
AAPL   149.33 (+0.01%)
MSFT   323.76 (+4.40%)
FB   315.44 (-0.12%)
GOOGL   2,956.75 (+6.12%)
TSLA   1,051.03 (+3.20%)
AMZN   3,399.17 (+0.68%)
NVDA   248.76 (+0.64%)
BABA   168.97 (-0.60%)
NIO   39.81 (-1.63%)
CGC   13.02 (-1.14%)
GE   104.15 (-3.06%)
AMD   124.40 (+1.20%)
MU   68.33 (-0.88%)
T   25.19 (-0.71%)
F   15.73 (-1.32%)
ACB   6.96 (-1.00%)
DIS   169.69 (-1.37%)
PFE   42.85 (-1.63%)
BA   207.30 (-1.20%)
AMC   35.35 (-1.94%)
S&P 500   4,576.01 (+0.03%)
DOW   35,659.22 (-0.27%)
QQQ   382.12 (+0.79%)
AAPL   149.33 (+0.01%)
MSFT   323.76 (+4.40%)
FB   315.44 (-0.12%)
GOOGL   2,956.75 (+6.12%)
TSLA   1,051.03 (+3.20%)
AMZN   3,399.17 (+0.68%)
NVDA   248.76 (+0.64%)
BABA   168.97 (-0.60%)
NIO   39.81 (-1.63%)
CGC   13.02 (-1.14%)
GE   104.15 (-3.06%)
AMD   124.40 (+1.20%)
MU   68.33 (-0.88%)
T   25.19 (-0.71%)
F   15.73 (-1.32%)
ACB   6.96 (-1.00%)
DIS   169.69 (-1.37%)
PFE   42.85 (-1.63%)
BA   207.30 (-1.20%)
AMC   35.35 (-1.94%)
NYSEARCA:CANE

Teucrium Sugar Fund Stock Forecast, Price & News

$9.44
+0.08 (+0.85 %)
(As of 10/26/2021 12:00 AM ET)
Add
Today's Range
$9.38
$9.47
50-Day Range
$9.18
$9.79
52-Week Range
$6.06
$9.81
Volume80,182 shs
Average Volume87,046 shs
Market Capitalization$26.20 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive CANE News and Ratings via Email

Sign-up to receive the latest news and ratings for Teucrium Sugar Fund and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Teucrium
Fund NameTeucrium Sugar Fund
Tax ClassificationPartnership
SymbolNYSEARCA:CANE
Inception Date9/16/2011
Fund ManagerSteve Kahler
PhoneN/A

Fund Focus

Asset ClassCommodities
BenchmarkSugar Futures Contract Benchmark
CategoryAgriculture
FocusSugar
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$26.25 million
Average Daily Volume$114,114.30
Discount/Premium-0.02%

ETF Expenses

Management Fee1.00%
Other Expenses2.58%
Total Expenses3.58%
Fee Waiver0.00%
Net Expenses3.58%

Administrator, Advisor and Custodian

AdministratorU.S. Bancorp Fund Services, LLC
AdvisorTeucrium Trading, LLC
CustodianU.S. Bank, N.A.
DistributorForeside Fund Services, LLC
Transfer AgentU.S. Bank, N.A.
TrusteeWilmington Trust Company
Lead Market MakerPundion

Geographic Exposure of CANE

Currency Exposure of CANE













Teucrium Sugar Fund (NYSEARCA:CANE) Frequently Asked Questions

What stocks does MarketBeat like better than Teucrium Sugar Fund?

Wall Street analysts have given Teucrium Sugar Fund a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Teucrium Sugar Fund wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Teucrium Sugar Fund's stock been impacted by Coronavirus (COVID-19)?

Teucrium Sugar Fund's stock was trading at $6.30 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CANE stock has increased by 49.8% and is now trading at $9.44.
View which stocks have been most impacted by COVID-19
.

Who are Teucrium Sugar Fund's key executives?

Teucrium Sugar Fund's management team includes the following people:
  • Sal Gilbertie, President (Age 50)
  • Dale Riker, Treasurer, Secretary (Age 54)
  • Carl N. Miller III, Member of the Management (Age 59)
  • Kelly Teevan, Member of the Management (Age 59)

What other stocks do shareholders of Teucrium Sugar Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teucrium Sugar Fund investors own include Freeport-McMoRan (FCX), Rio Tinto Group (RIO), BHP Group (BBL), Cameco (CCJ), Franco-Nevada (FNV), Nutrien (NTR), Royal Gold (RGLD), Seabridge Gold (SA), Tesla (TSLA) and Teucrium Soybean Fund (SOYB).

What is Teucrium Sugar Fund's stock symbol?

Teucrium Sugar Fund trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "CANE."

How do I buy shares of Teucrium Sugar Fund?

Shares of CANE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teucrium Sugar Fund's stock price today?

One share of CANE stock can currently be purchased for approximately $9.44.

How much money does Teucrium Sugar Fund make?

Teucrium Sugar Fund has a market capitalization of $26.20 million.

What is Teucrium Sugar Fund's official website?

The official website for Teucrium Sugar Fund is teucrium.com.


This page was last updated on 10/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.